4D Molecular Therapeutics Inc

NASDAQ:FDMT   3:59:54 PM EDT
32.68
-0.26 (-0.79%)
Products

4D Molecular Therapeutics Inc Announces FDA Clearance Of Ind Application For 4D-150

Published: 10/06/2021 11:44 GMT
4D Molecular Therapeutics Inc (FDMT) - 4d Molecular Therapeutics Announces FDA Clearance of Ind Application for 4d-150, a Dual-transgene Intravitreal Gene Therapy for Patients With Wet Amd.
4d Molecular Therapeutics Inc - Active Ind Enables Initiation of 4d-150 Phase 1/2 Clinical Trial Sites, Which is Expected Before Year-end.